Euromed Partners with Biotherapeutics to Launch ABALife™

10.03.17 ABALife™ fig fruit extract for glycemic control and carbohydrate metabolism. Euromed SA has received an exclusive license agreement with BioTherapeutics Inc. for patented technology for abscisic acid (ABA). The patents licensed by Euromed are titled: “Method of using abscisic acid to treat diseases and disorders” (Patent numbers 7,741,1367 and 8,367,727, and the Inventors are Josep … Continue reading

03/10/2017 Uncategorized

Euromed Launching a New Extract at SSW17

Date: September 27 – 28, 2017 Location: Las Vegas, Nevada, USA Our teams from Europe and US were busy at Stand NN123 providing information on the broad list of Euromed extracts, including our newest ABAlife™, an innovative fig fruit extract standardized in abscisic acid (ABA), indicated for blood glucose management, officially launched at SSW. The … Continue reading

28/09/2017 Uncategorized

Euromed acquired by private equity firm

Firm Invests In Spanish Herbal Supplement Specialist The Riverside Company has acquired Euromed S.A. (Euromed). Euromed provides standardized herbal extracts and natural active substances for the pharmaceutical, dietary supplement and cosmetic industries. Euromed is a corporate carve-out from Meda, a Swedish pharmaceutical company. Based in Barcelona, Euromed processes more than 4,000 tons of raw materials … Continue reading

30/12/2015 Uncategorized
Our site uses cookies. By continuing to use our site you are agreeing to our cookies policy. OK